Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

More articles from Clinical Investigation

  • Unspecific <sup>18</sup>F-PSMA-1007 Bone Uptake Evaluated Through PSMA-11 PET, Bone Scanning, and MRI Triple Validation in Patients with Biochemical Recurrence of Prostate Cancer
    You have access
    Unspecific 18F-PSMA-1007 Bone Uptake Evaluated Through PSMA-11 PET, Bone Scanning, and MRI Triple Validation in Patients with Biochemical Recurrence of Prostate Cancer
    Robert Seifert, Tugce Telli, Marcel Opitz, Francesco Barbato, Christoph Berliner, Michael Nader, Lale Umutlu, Martin Stuschke, Boris Hadaschik, Ken Herrmann and Wolfgang P. Fendler
    Journal of Nuclear Medicine May 1, 2023, 64 (5) 738-743; DOI: https://doi.org/10.2967/jnumed.118.215434
  • A Pilot Study of <sup>68</sup>Ga-PSMA11 and <sup>68</sup>Ga-RM2 PET/MRI for Biopsy Guidance in Patients with Suspected Prostate Cancer
    You have access
    A Pilot Study of 68Ga-PSMA11 and 68Ga-RM2 PET/MRI for Biopsy Guidance in Patients with Suspected Prostate Cancer
    Heying Duan, Pejman Ghanouni, Bruce Daniel, Jarrett Rosenberg, Alan Thong, Christian Kunder, Carina Mari Aparici, Guido A. Davidzon, Farshad Moradi, Geoffrey A. Sonn and Andrei Iagaru
    Journal of Nuclear Medicine May 1, 2023, 64 (5) 744-750; DOI: https://doi.org/10.2967/jnumed.122.264448
  • Toward Single-Time-Point Image-Based Dosimetry of <sup>177</sup>Lu-PSMA-617 Therapy
    Open Access
    Toward Single-Time-Point Image-Based Dosimetry of 177Lu-PSMA-617 Therapy
    Julia Brosch-Lenz, Astrid Delker, Friederike Völter, Lena M. Unterrainer, Lena Kaiser, Peter Bartenstein, Sibylle Ziegler, Arman Rahmim, Carlos Uribe and Guido Böning
    Journal of Nuclear Medicine May 1, 2023, 64 (5) 767-774; DOI: https://doi.org/10.2967/jnumed.122.264594
  • <sup>64</sup>Cu Treatment Planning and <sup>67</sup>Cu Therapy with Radiolabeled [<sup>64</sup>Cu/<sup>67</sup>Cu]MeCOSar-Octreotate in Subjects with Unresectable Multifocal Meningioma: Initial Results for Human Imaging, Safety, Biodistribution, and Radiation Dosimetry
    You have access
    64Cu Treatment Planning and 67Cu Therapy with Radiolabeled [64Cu/67Cu]MeCOSar-Octreotate in Subjects with Unresectable Multifocal Meningioma: Initial Results for Human Imaging, Safety, Biodistribution, and Radiation Dosimetry
    Dale L. Bailey, Kathy P. Willowson, Matthew Harris, Colin Biggin, Alireza Aslani, Nigel A. Lengkeek, Jon Stoner, M. Enid Eslick, Harry Marquis, Michelle Parker, Paul J. Roach and Geoffrey P. Schembri
    Journal of Nuclear Medicine May 1, 2023, 64 (5) 704-710; DOI: https://doi.org/10.2967/jnumed.122.264586
  • Noninvasive Assessment of Human Epidermal Growth Factor Receptor 2 (HER2) in Esophagogastric Cancer Using <sup>89</sup>Zr-Trastuzumab PET: A Pilot Study
    You have access
    Noninvasive Assessment of Human Epidermal Growth Factor Receptor 2 (HER2) in Esophagogastric Cancer Using 89Zr-Trastuzumab PET: A Pilot Study
    Melissa A. Lumish, Steven B. Maron, Viktoriya Paroder, Joanne F. Chou, Marinela Capanu, Steven Philemond, Joseph A. O’Donoghue, Heiko Schöder, Jason S. Lewis, Serge K. Lyashchenko, Neeta Pandit-Taskar and Yelena Y. Janjigian
    Journal of Nuclear Medicine May 1, 2023, 64 (5) 724-730; DOI: https://doi.org/10.2967/jnumed.122.264470
  • Utility of Amino Acid PET in the Differential Diagnosis of Recurrent Brain Metastases and Treatment-Related Changes: A Meta-analysis
    You have access
    Utility of Amino Acid PET in the Differential Diagnosis of Recurrent Brain Metastases and Treatment-Related Changes: A Meta-analysis
    Timo Schlürmann, Birgit Waschulzik, Stephanie Combs, Jens Gempt, Benedikt Wiestler, Wolfgang Weber and Igor Yakushev
    Journal of Nuclear Medicine May 1, 2023, 64 (5) 816-821; DOI: https://doi.org/10.2967/jnumed.122.264803
  • Molecular Imaging of Pulmonary Inflammation in Users of Electronic and Combustible Cigarettes: A Pilot Study
    Open Access
    Molecular Imaging of Pulmonary Inflammation in Users of Electronic and Combustible Cigarettes: A Pilot Study
    Reagan R. Wetherill, Robert K. Doot, Anthony J. Young, Hsiaoju Lee, Erin K. Schubert, Corinde E. Wiers, Frank T. Leone, Robert H. Mach, Henry R. Kranzler and Jacob G. Dubroff
    Journal of Nuclear Medicine May 1, 2023, 64 (5) 797-802; DOI: https://doi.org/10.2967/jnumed.122.264529
  • Long-Term Prognostic Value of <sup>82</sup>Rb PET/CT–Determined Myocardial Perfusion and Flow Reserve in Cancer Patients
    You have access
    Long-Term Prognostic Value of 82Rb PET/CT–Determined Myocardial Perfusion and Flow Reserve in Cancer Patients
    Josef J. Fox, Audrey Mauguen, Kimiteru Ito, Dipti Gupta, Alice Yu, Thomas H. Schindler, H. William Strauss and Heiko Schöder
    Journal of Nuclear Medicine May 1, 2023, 64 (5) 791-796; DOI: https://doi.org/10.2967/jnumed.122.264795
  • Detection of Early Esophageal Neoplastic Barrett Lesions with Quantified Fluorescence Molecular Endoscopy Using Cetuximab-800CW
    You have access
    Detection of Early Esophageal Neoplastic Barrett Lesions with Quantified Fluorescence Molecular Endoscopy Using Cetuximab-800CW
    Ruben Y. Gabriëls, Lisanne E. van Heijst, Wouter T.R. Hooghiemstra, Anne M. van der Waaij, Gursah Kats-Ugurlu, Arend Karrenbeld, Dominic J. Robinson, Anna Tenditnaya, Vasilis Ntziachristos, Dimitris Gorpas and Wouter B. Nagengast
    Journal of Nuclear Medicine May 1, 2023, 64 (5) 803-808; DOI: https://doi.org/10.2967/jnumed.122.264656
  • Initial Results of <sup>68</sup>Ga-FAPI-46 PET/MRI to Assess Response to Neoadjuvant Chemotherapy in Breast Cancer
    You have access
    Initial Results of 68Ga-FAPI-46 PET/MRI to Assess Response to Neoadjuvant Chemotherapy in Breast Cancer
    Philipp Backhaus, Matthias C. Burg, Inga Asmus, Michaela Pixberg, Florian Büther, Hans-Jörg Breyholz, Randy Yeh, Stefanie B. Weigel, Patricia Stichling, Walter Heindel, Stefanie Bobe, Peter Barth, Joke Tio and Michael Schäfers
    Journal of Nuclear Medicine May 1, 2023, 64 (5) 717-723; DOI: https://doi.org/10.2967/jnumed.122.264871

Pages

  • Previous
  • Next
  • 1
  • …
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • …
  • 92
SNMMI

© 2025 SNMMI

Powered by HighWire